GlassScriptPhysician profile
Nhu Quynh Tran
NPI 1861414005
$13,258.26
in general payments reported to CMS, 2019-2025
19 companies · $933 in 2025
The $933 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,929 · 2020: $1,447 · 2021: $1,135 · 2022: $1,677 · 2023: $4,304 · 2024: $1,833 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,920 · Consulting Fee: $3,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,920.31 |
| Consulting Fee | $3,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $6,655.32 | 2019-2025 | Prolia, Evenity, Otezla |
| Glaxosmithkline, LLC. | $1,299.17 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Radius Health, INC. | $1,144.81 | 2019-2025 | Tymlos |
| Amarin Pharma, INC. | $952.13 | 2019-2023 | |
| Lilly USA, LLC | $906.27 | 2020-2025 | Jardiance, Mounjaro, Trulicity |
| Novo Nordisk INC | $677.30 | 2020-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $436.90 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $399.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $335.40 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $128.45 | 2019 | |
| Pfizer INC. | $72.49 | 2019-2024 | |
| Alvogen INC | $51.96 | 2024-2025 | Teriparatide |
| Medtronic, INC. | $48.15 | 2023 | Biomedicus |
| Abbvie INC. | $45.51 | 2022 | |
| Merck Sharp & Dohme LLC | $34.26 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $21.61 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.49 | 2021 | |
| Abbott Laboratories | $15.31 | 2025 | Gallant |
| Covis Pharma Gmbh | $14.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nhu Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.